COMP <GO>
CDRE vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Cadre Holdings Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CDRE 6
— UNH 7
■ METRIC PARITY
LAST: $31.10 (+3.81%) • MKT CAP: $1.33B
options-implied-move
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDRE VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDRE | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 88.57% | -46.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.00% | 11.47% | -0.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.5x | 16.4x | +4.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 6.48% | -2.21 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.00% | 4.82% | +6.18 | CDRE | /operating-margins <GO> |
| Net Profit Margin | 7.20% | 3.14% | +4.06 | CDRE | /net-margins <GO> |
| Revenue Growth (YoY) | 7.50% | 6.46% | +1.04 | CDRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.16% | 2.28% | -1.12 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 3.12 | +0.20 | CDRE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | CDRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.2 | 59.2 | +9.00 | CDRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 17.7x | +10.36 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.33B | $368.83B | -$367.50B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDRE REV | UNH REV | CDRE GROSS % | UNH GROSS % | CDRE FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $610.3M | $447.57B | 42.5% | 88.7% | $56.8M | $16.07B |
| FY 2024 | $567.6M | $400.28B | 41.1% | 88.3% | $26.1M | $20.70B |
| FY 2023 | $482.5M | $371.62B | — | 89.6% | $73.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDRE // BETA —
UNH // BETA 0.33